Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1136/bcr-2021-242220 http://scihub22266oqcxt.onion/10.1136/bcr-2021-242220 34059544!8169472!34059544     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       BMJ+Case+Rep 2021 ; 14 (5): ä Nephropedia Template TP {{tp|p=34059544|t=2021. Secondary immune thrombocytopenia supposedly attributable to COVID-19 vaccination |pdf=|usr=}}{{34059544}} gab.com Text Secondary immune thrombocytopenia supposedly attributable to COVID-19 vaccination JO: BMJ Case Rep http://www.kidney.de/pget.php?&tw=1&pmid=34059544 #FOAvip Immune thrombocytopenia (ITP) has been widely reported as a complication of SARS-CoV-2 infection, but to our knowledge, there have been no reports on the association of the COVID-19 vaccine with thrombocytopenia. Here, we report a case of secondary ITP in a patient who was recently immunised with the messenger RNA COVID-19 vaccine BNT162b2 (Pfizer-BioNTech). Twit Text FOAVip Secondary immune thrombocytopenia supposedly attributable to COVID-19 vaccination ????BMJ Case Rep http://www.kidney.de/pget.php?&tw=1&pmid=34059544 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34059544 #FOAvip English Wikipedia <ref>{{Cite pmid|34059544}}</ref> Secondary immune thrombocytopenia supposedly attributable to COVID-19 vaccination #MMPMID34059544 Fueyo-Rodriguez O; Valente-Acosta B; Jimenez-Soto R; Neme-Yunes Y; Inclan-Alarcon SI; Trejo-Gonzalez R; Garcia-Salcido MA BMJ Case Rep 2021[May]; 14 (5): ä PMID34059544show ga Immune thrombocytopenia (ITP) has been widely reported as a complication of SARS-CoV-2 infection, but to our knowledge, there have been no reports on the association of the COVID-19 vaccine with thrombocytopenia. Here, we report a case of secondary ITP in a patient who was recently immunised with the messenger RNA COVID-19 vaccine BNT162b2 (Pfizer-BioNTech). |*COVID-19[MESH] |*Purpura, Thrombocytopenic, Idiopathic[MESH] |*Thrombocytopenia[MESH] |BNT162 Vaccine[MESH] |COVID-19 Vaccines[MESH] |Humans[MESH] |SARS-CoV-2[MESH]Secondary immune thrombocytopenia supposedly attributable to COVID-19 (epmc).pdf DeepDyve Pubget Overpricing